Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Cardiac events in stage III NSCLC treated in daily clinical practice

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 25.10.18
Views: 1173

Dr Juliette Degens - Academisch Ziekenhuis Maastricht, Maastricht, Netherlands

Dr Juliette Degens speaks with ecancer at ESMO 2018 in Munich about her study investigating the incidents of pre-existed cardiac comorbidity and cardiac incidents after diagnosis of lung cancer in patients that would be treated in daily clinical practice.

Dr Degens explains that 30% of patients had pre existing cardiac comorbidity and that 33% of patients developed a new cardiac event within 5 years of diagnosis.

ecancer's filming has been kindly supported by MSD through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

CML Life Banner

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation